Palvella Therapeutics (PVLA) EPS (Basic) (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.11% |
| Dec 31, 2025 | -4.85% |
| Sep 30, 2025 | -19.77% |
| Jun 30, 2025 | -16.22% |
| Mar 31, 2025 | -716.67% |
| Dec 31, 2024 | 103.05% |
| Sep 30, 2024 | -59.51% |
| Jun 30, 2024 | -60.39% |
| Mar 31, 2024 | -107.50% |
| Dec 31, 2023 | 335.86% |
| Sep 30, 2023 | -339.67% |
| Jun 30, 2023 | 125.65% |
| Sep 30, 2022 | 7.14% |
| Jun 30, 2022 | -100.00% |
| Mar 31, 2022 | 46.15% |
| Dec 31, 2021 | 45.83% |
| Sep 30, 2021 | 4.00% |
| Jun 30, 2021 | -257.14% |
| Mar 31, 2021 | 73.08% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | -188.89% |
| Jun 30, 2020 | -28.57% |
| Mar 31, 2020 | -16.67% |
| Dec 31, 2019 | -20.00% |
| Sep 30, 2019 | 79.17% |
| Jun 30, 2019 | -20.00% |
| Mar 31, 2019 | 4.76% |
| Dec 31, 2018 | -90.91% |
| Sep 30, 2018 | -2,825.19% |
| Jun 30, 2018 | 97.79% |
| Mar 31, 2018 | -194.44% |
| Dec 31, 2017 | 212.50% |
| Sep 30, 2017 | 30.43% |
| Jun 30, 2017 | -21.05% |
| Mar 31, 2017 | -18.75% |
| Dec 31, 2016 | -14.29% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | -40.00% |
| Mar 31, 2016 | -42.86% |
| Dec 31, 2015 | 30.00% |
| Sep 30, 2015 | 16.67% |
| Jun 30, 2015 | 7.69% |
| Sep 30, 2014 | 29.17% |
| Jun 30, 2014 | -242.86% |
| Mar 31, 2014 | -37,571.89% |
| Dec 31, 2013 | 80.33% |
| Sep 30, 2013 | -1,623.70% |